Clinical and Translational Science Awards
NCATS Clinical and Translational Science Awards (CTSA) program is designed to strengthen and support the entire spectrum of translational research from scientific discovery to improved patient care. Under NCATS leadership, the program currently supports a national consortium of more than 60 medical research institutions that work together to transform this process.
CTSA support enables research teams to collaborate to tackle common problems that no one organization can overcome alone. Program goals include accelerating laboratory discoveries into new treatments for patients, training the next generation of clinical and translational researchers, and engaging communities in clinical research efforts.
About the CTSA Program
Find out more about the CTSA program, its history and currently funded institutions.
This funding announcement includes application instructions, eligibility information and details about the evolution of the program. View all of NCATS’ current funding opportunities.
Training and Career Development
NCATS trains, cultivates and sustains future leaders of the biomedical research workforce through the CTSA program. Learn more about how the program is supporting a new generation of clinical and translational researchers.
Engaging Communities in Research
To ensure that broad and unique community health needs are addressed, research institutions must collaborate with community organizations throughout the research process. Through the CTSA program, NCATS supports a broad range of efforts that engage communities to address health concerns and encourage participation in clinical research.
Petra Kaufmann, M.D., M.Sc.
Director, Division of Clinical Innovation
New Funding Opportunity
Date: Wednesday, Sept. 17, 2014
Time: noon-1 p.m. EDT
Working Group Addresses IOM's CTSA Findings
CTSAs at Work
Multisite studies give researchers access to large numbers of participants and foster collaboration among diverse disciplines. Read more about how CTSA-funded investigators are working to address the translational barrier of institutional review board oversight in multisite studies.